Skip to content
Home/Companies/Biotech/StratifAI
StratifAI

StratifAI

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns StratifAI?

StratifAI is a German Biotech company, currently owned by Heliad AG since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Heliad AG
Investor
Heliad AG
Heliad Evergreen Holdings · 2003 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.stratifai.com

More from Heliad Evergreen Holdings

Other portfolio companies in the same fund.

Bayshore AI
Active
SaaSGermany· 2026
GeneralMind
GeneralMind
Active
AI/MLGermany· 2026
Project Q
Active
Aerospace & DefenceGermany· 2026
Aikido Security
Aikido Security
Active
CybersecurityBelgium· 2025
Albacore
Albacore
Active
Aerospace & DefenceGermany· 2025
ARX Robotics
Active
Deep TechGermany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns StratifAI?

StratifAI is currently owned by Heliad AG, through Heliad Evergreen Holdings, since 2025.

When did Heliad AG acquire StratifAI?

Heliad AG acquired StratifAI in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue